Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma: A Randomized Clinical Trial

NCT07240454 is registered in ClinicalTrials.gov with Tao Liu as lead sponsor.

NCT NCT07240454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07240454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma: A Randomized Clinical Trial
Lead sponsor
Tao Liu
Phase
Not applicable
Overall status
Recruiting
Start date
October 15, 2025
Completion date
December 31, 2028
Enrollment
143 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma